Tribune News Network
Doha
Sidra Medicine, a member of Qatar Foundation, has signed a memorandum of understanding (MoU) with Germany-based Vitafluence.ai GmbH and its Swiss venture studio, EmpathicAI.Life, to explore potential collaborations in the field of artificial intelligence (AI) and digital health innovation.
The MoU outlines a framework for a three-year collaboration focused on the joint development of initiatives to advance AI-powered healthcare delivery as well as foster innovation within Sidra Medicine’s academic medical ecosystem.
The agreement will set the groundwork for pilot programmes, knowledge exchange, and co-development of digital solutions designed to support clinical decision-making and personalise patient care.
The MoU was signed by Dr Iyabo Tinubu-Karch, CEO of Sidra Medicine, and Dr Peter O. Owotoki, co-founder of Vitafluence.ai.
The signing ceremony was attended by Ambassador of Switzerland to Qatar Her Excellency Florence Tinguely Mattli, Economic & Commercial Officer, Swiss Business Hub Middle East-Qatar Sarra Messaoudi, as well as Chief Research Officer Prof Khalid Fakhro, Executive Director of Commercial Development Samuel Lock, and Director - Research Operations, Innovation and Strategy, Sidra Medicine Marla Beerens.
Dr Tinubu-Karch said, “Our joint research, clinical and medical education programmes are designed to embrace emerging technologies that can revolutionise diagnostics, treatment and patient care. Working with Vitafluence.ai gives us the opportunity to explore a range of AI-driven applications, including predictive modelling, AI-assisted diagnostics, and tailored treatment pathways, that align with our mission of delivering world-class precision medicine for our patients.”
Vitafluence.ai brings deep expertise in developing proprietary AI models and platforms that power data-driven decision-making in healthcare and life sciences. Working in tandem with Empathic AI’s venture incubation capabilities, the collaboration will evaluate how cutting-edge technologies can be adapted to the specific needs of Sidra Medicine’s clinical and research environment.
Dr Owotoki said, “We are truly excited to partner with Sidra Medicine as part of this innovative journey. This collaboration represents an incredible opportunity to contribute to Qatar’s ambitious vision for medical and digital health advancement, and most importantly, to work together in delivering impactful outcomes for women and children.”
Vitafluence and EmpathicAILife will collaborate with Sidra Medicine’s clinical and operational teams to ensure that all initiatives uphold the highest standards of safety, ethics, and patient-centred care. The partnership lays the groundwork for introducing cutting-edge digital health solutions into Sidra Medicine’s ecosystem, driving forward its commitment to innovation and excellence in care.
Sidra Medicine will be exploring the transformative role of artificial intelligence in advancing global healthcare at its upcoming AI & Medicine 2025 conference from April 23 to 26, 2025.
